Cantor Fitzgerald Notes Amarin (AMRN) Pharmacoeconomic Analysis Results 'Is ICER-ing On The Cake'
Tweet Send to a Friend
Cantor Fitzgerald analyst Louise Chen weighed in on Amarin Corporation (NASDAQ: AMRN) after ICER released a Draft Evidence Report assessing ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
